PBI13 Budget Impact Analysis to Assess The Impact of Adalimumab-atto (Biosimilar) Compared to Adalimumab in Autoimmune Diseases in United Arab Emirates
Abstract
Authors
M. Farghally M.A. Sara Ahmad Y. Sharma M. Shamekh O. Mohamed